In fiscal year 2025, BIO PORT KOREA (188040) reported revenue of 70.9 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 70.9 billion KRW | 830 million KRW | -1.4 billion KRW | [source] |
| 2024 | 73.3 billion KRW | 5.2 billion KRW | 4.1 billion KRW | [source] |
| 2023 | 68.7 billion KRW | 4.9 billion KRW | 3.4 billion KRW | — |
| 2022 | 60.5 billion KRW | 3.2 billion KRW | 2.3 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 56.8 billion KRW | 16.7 billion KRW | 40.2 billion KRW | [source] |
| 2024 | 47.8 billion KRW | 19.2 billion KRW | 28.6 billion KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|---|---|---|---|
| 2025 | 4.7 billion KRW | 1.8 billion KRW | -3.7 billion KRW | [source] |
| 2024 | 12.1 billion KRW | -1.4 billion KRW | -6.4 billion KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.
Cash flow figures for the relevant year were not collected.